ZANNA, Ines
 Distribuzione geografica
Continente #
NA - Nord America 651
EU - Europa 107
AS - Asia 30
Totale 788
Nazione #
US - Stati Uniti d'America 648
IT - Italia 41
CN - Cina 18
DE - Germania 11
SE - Svezia 10
GB - Regno Unito 9
RO - Romania 9
RU - Federazione Russa 9
IE - Irlanda 4
IN - India 4
BE - Belgio 3
CA - Canada 3
UA - Ucraina 3
AT - Austria 2
HK - Hong Kong 2
IR - Iran 2
BD - Bangladesh 1
CH - Svizzera 1
DK - Danimarca 1
FI - Finlandia 1
FR - Francia 1
GR - Grecia 1
KR - Corea 1
NL - Olanda 1
SG - Singapore 1
UZ - Uzbekistan 1
Totale 788
Città #
Fairfield 97
Chandler 82
Ashburn 66
Woodbridge 55
Wilmington 44
Seattle 35
Houston 34
Cambridge 31
Ann Arbor 26
Altamura 18
Des Moines 18
Medford 12
Lawrence 10
Princeton 10
Dearborn 8
San Diego 7
Munich 6
Nanjing 6
Falls Church 5
Rome 5
Saint Petersburg 5
Beijing 4
Dublin 4
Ludwigshafen am Rhein 4
Palermo 4
Phoenix 4
Brussels 3
Santa Fe 3
Boardman 2
Changsha 2
Kumar 2
London 2
Mazara del Vallo 2
Nanchang 2
New York 2
Norwalk 2
Orange 2
Shenyang 2
Toronto 2
Venice 2
Vienna 2
Alexandria 1
Andover 1
Boston 1
Central 1
Copenhagen 1
Groningen 1
Hebei 1
Helsinki 1
Kilburn 1
New Orleans 1
Pune 1
San Giovanni Rotondo 1
Seongnam 1
Singapore 1
Southwark 1
Tappahannock 1
Tehran 1
Tianjin 1
Tulsa 1
Wandsworth 1
Washington 1
Winnipeg 1
Totale 654
Nome #
Insight into genetic susceptibility to male breast cancer by multigene panel testing: Results from a multicenter study in Italy 124
Novel and known genetic variants for male breast cancer risk at 8q24.21, 9p21.3, 11q13.3 and 14q24.1: Results from a multicenter study in Italy 112
Association of SULT1A1 Arg213His polymorphism with male breast cancer risk: results from a multicenter study in Italy 106
Whole-exome sequencing and targeted gene sequencing provide insights into the role of PALB2 as a male breast cancer susceptibility gene 101
Male breast cancer in BRCA1 and BRCA2 mutation carriers: Pathology data from the Consortium of Investigators of Modifiers of BRCA1/2 87
DNA ploidy and S-phase fraction, but not p53 or NM23-H1 expression, predict outcome in colorectal cancer patients. Result of a 5-year prospective study 77
DNA aneuploidy and high proliferative activity but not K-ras-2 mutations as independent predictors of clinical outcome in operable gastric carcinoma: Results of a 5-year Gruppo Oncologico dell'Italia Meridionale (GOIM) prospective study 65
Specific codon 13 K-ras mutations are predictive of clinical outcome in colorectal cancer patients, whereas codon 12 K-ras mutations are associated with mucinous histotype 63
Prognostic significance of p16INK4a alterations and 9p21 loss of heterozigosity in locally advanced laryngeal squamous cell carcinoma 59
Hereditary common cancers: Molecular and clinical genetics 44
Totale 838
Categoria #
all - tutte 3.497
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.497


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201932 0 0 0 0 0 0 0 0 0 0 19 13
2019/2020192 13 8 6 31 23 31 18 20 19 10 10 3
2020/2021151 6 5 7 8 52 4 6 10 11 23 7 12
2021/2022139 8 20 8 8 2 8 10 9 13 21 10 22
2022/2023233 29 49 8 21 24 30 12 20 31 0 7 2
2023/202462 5 7 2 17 0 10 13 5 2 1 0 0
Totale 838